For nearly 60 years, doctors have measured cholesterol levels in the blood to identify people at risk of heart disease. But a ...

An experimental treatment called VERVE-102 lowers the amount of "bad" cholesterol in the blood of people with specific ...

Dyslipidemia, marked by abnormal cholesterol and triglyceride levels, remains a major health risk in developing countries and ...

A new study shows young adults with higher exposure to atherogenic lipoprotein particles may be at a greater risk of ...

Drinking a cup of hibiscus tea each day can help control blood pressure. Here's what to expect if you add this supplement to ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.

One of the most rampant diseases today is driven due to the fluctuation in the cholesterol levels. Know exactly what it is ...

Zodasiran targets ANGPLT3, an emerging therapeutic target to treat HoFH and other dyslipidemias – YOSEMITE Phase 3 study further enhances Arrowhead’s late-stage pipeline o ...

The placebo-controlled study is aimed at assessing the safety and efficacy of zodasiran in adults and adolescents with HoFH.

Elevated HDL-C levels more than doubled the risk of low muscle mass in the entire cohort (OR = 2.28). In older men, the risk of low muscle mass was three times higher with increased HDL-C levels (OR = ...

This study identified important metabolic changes in adipose tissue in broiler chickens exposed to high temperatures. Higher lipoprotein lipase levels lead to higher fat accumulation, making poultry ...

The result? ApoB count was the strongest and most reliable predictor of heart disease. This marker, which reflects the number ...